Joint

Joint Net Debt / EBITDA

The Net Debt to EBITDA of Joint (JYNT) as of Nov 17, 2026 is -29.23. In the previous year, Net Debt to EBITDA was 46.86 — a change of -162.37% (lower).

Net Debt / EBITDA

-29.23

YoY

-162.37%

Last updated:

Net Debt to EBITDA of Joint is 2025 -29.23 . Net Debt to EBITDA of Joint was 2024 46.86 . It decreases by -162.37% lower compared to the previous year.

The Joint Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2018
-4.22 USD
Jan 1, 2019
1.09 USD
Jan 1, 2020
-0.25 USD
Jan 1, 2021
0.41 USD
Jan 1, 2022
2.20 USD
Jan 1, 2023
-9.58 USD
Jan 1, 2024
46.86 USD
Jan 1, 2025
-29.23 USD
The Joint Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
-29.23-162.37%
46.86-589.18%
-9.58-536.25%
2.20+437.28%
0.41-261.55%
-0.25-123.11%
1.09-125.94%
-4.22-259.09%
2.65+1,130.20%
0.22-89.34%
2.02-85.64%
14.08-195.41%
-14.75-381.33%
5.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

Net Debt to EBITDA of Joint is -29.23 in 2025.

Net Debt to EBITDA of Joint changed from 46.86 to -29.23, representing a -162.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Joint since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Joint with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Joint

All Key Metrics — Joint